TVRD — Tvardi Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-07-07 | Tweardy Samuel David | Other Acquisition/Disposition | 315.7K | 0.00 | 0 |
| 2025-07-07 | Tweardy Samuel David | Other Acquisition/Disposition | 315.7K | 0.00 | 0 |
| 2025-04-15 | Wirk Shaheen Director | Grant or award | 176.0K | — | — |
| 2025-04-15 | Wirk Shaheen Director | Grant or award | 263.2K | — | — |
| 2025-04-15 | Wirk Shaheen Director | Other Acquisition/Disposition | 263.2K | — | — |
| 2025-04-15 | Wirk Shaheen Director | Grant or award | 4.2K | — | — |
| 2025-04-15 | HALL WALLACE L JR Director | Grant or award | 202.0K | — | — |
| 2025-04-15 | Wirk Shaheen Director | Other Acquisition/Disposition | 176.0K | — | — |
| 2025-04-15 | HALL WALLACE L JR Director | Other Acquisition/Disposition | 202.0K | — | — |
| 2025-04-15 | HALL WALLACE L JR Director | Grant or award | 44.7K | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Slate Path Capital LP | 2.2M | 704.1K |
| BlackRock, Inc. | 1.2M | 388.1K |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | 344.7K |
| AMERICAN FINANCIAL GROUP INC | 711.2K | 223.7K |
| GEODE CAPITAL MANAGEMENT, LLC | 580.0K | 182.3K |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 321.3K | 101.0K |
| STATE STREET CORP | 309.2K | 97.2K |
| RENAISSANCE TECHNOLOGIES LLC | 292.9K | 92.1K |
| MORGAN STANLEY | 231.8K | 72.9K |
| Duncan Williams Asset Management, LLC | 201.1K | 63.2K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 8-K | 2026-07-30 | 2026-07-30 | on EDGAR ↗ |
| 8-K | 2026-07-17 | 2026-07-17 | on EDGAR ↗ |
| 424B5 | 2026-07-17 | — | on EDGAR ↗ |
| 8-K | 2026-07-07 | 2026-07-07 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-09 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-09 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Tvardi Therapeutics, Inc. (TVRD) filed form 8-K · 2026-08-14 · SEC EDGAR
- Tvardi Therapeutics, Inc. (TVRD) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Tvardi Therapeutics, Inc. (TVRD) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about TVRD
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →